Cardinal Health (NYSE:CAH) Updates FY 2025 Earnings Guidance

Cardinal Health (NYSE:CAH) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 7.750-7.900 for the period, compared to the consensus EPS estimate of 7.630. The company issued revenue guidance of -. Cardinal Health also updated its FY25 guidance to $7.75-7.90 EPS.

Analyst Ratings Changes

Several brokerages have recently commented on CAH. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday. Argus increased their price target on Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, September 11th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cardinal Health from $119.00 to $124.00 and gave the stock a “hold” rating in a report on Monday. Wells Fargo & Company increased their target price on shares of Cardinal Health from $95.00 to $101.00 and gave the company an “underweight” rating in a report on Thursday, August 15th. Finally, Barclays boosted their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an “overweight” rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $123.00.

Cardinal Health Trading Down 2.9 %

Shares of CAH stock traded down $3.39 during trading hours on Monday, hitting $112.74. 1,600,052 shares of the company were exchanged, compared to its average volume of 2,071,188. The stock has a market capitalization of $27.28 billion, a price-to-earnings ratio of 22.07, a P/E/G ratio of 1.49 and a beta of 0.60. The firm has a fifty day simple moving average of $111.75 and a 200 day simple moving average of $104.17. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $119.13.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.64 by $0.24. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. During the same period last year, the business posted $1.73 earnings per share. The business’s revenue for the quarter was down 4.3% on a year-over-year basis. Sell-side analysts anticipate that Cardinal Health will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Tuesday, October 1st were issued a dividend of $0.506 per share. The ex-dividend date was Tuesday, October 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.02 annualized dividend and a yield of 1.80%. Cardinal Health’s dividend payout ratio is 39.30%.

Insiders Place Their Bets

In related news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the sale, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, insider Michelle D. Greene sold 4,000 shares of the company’s stock in a transaction dated Monday, August 19th. The stock was sold at an average price of $108.85, for a total transaction of $435,400.00. Following the sale, the insider now directly owns 19,242 shares in the company, valued at $2,094,491.70. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jessica L. Mayer sold 17,896 shares of the firm’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares of the company’s stock, valued at $10,065,447.92. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 113,963 shares of company stock worth $12,379,980 over the last quarter. 0.09% of the stock is currently owned by company insiders.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.